Eris Lifesciences IPO opens on June 16 at ₹600-603 a share

Our Bureau Mumbai | Updated on January 12, 2018 Published on June 09, 2017

Gujarat-based Eris Lifesciences’ existing shareholders plans to offer 2.89 crore shares in the price band of ₹600-603 through an IPO, which will open on June 16 and close on June 20.

The number of shares offered includes 2.2 crore shares, or 16.25 per cent stake held by PE giant ChrysCapital’s investment arm Botticelli. The remaining stake is to be sold by founder Amit Bakshi and other investors, including Himanshu Shah and Rakesh Shah, among others. Bids can be made for a minimum of 24 equity shares.

Eris develops, manufactures and commercialises branded pharma products in select therapeutic areas within the chronic and acute categories, which are linked to lifestyle-related disorders.

Published on June 09, 2017
This article is closed for comments.
Please Email the Editor